Data, AI To Command Center Stage In The 21st Edition
India: BioAsia, the premier healthcare and Life Sciences event organized by the Government of Telangana, is gearing up for its 21st edition in Hyderabad. Sri Duddilla Sridhar Babu, Minister for Information Technology, Industries & Commerce, conducted a thorough review of the preparations for the upcoming global conference. As the flagship event of the Government of Telangana, BioAsia has become a key player in shaping the life sciences development landscape in India, redirecting attention towards industry advancements and challenges.
Scheduled to take place from February 26 to 28, 2024, at the Hyderabad International Convention Center (HICC), the 21st edition of BioAsia will bring together government dignitaries, industry leaders, researchers, entrepreneurs, and other delegates. The theme for this edition is “Data & AI: Redefining Possibilities,” aiming to explore the potential of reshaping the future of healthtech delivery in the country.
With a distinguished lineup of 70+ influential speakers, including global CEOs and industry leaders, the event will feature keynote speakers such as Mr. David Ricks (CEO, Eli Lilly and Company), Dr. Christopher Boerner (Incoming CEO, Bristol Myers Squibb), Mr. Geoff Martha (Chairman and CEO, Medtronic), and Prof. Gregg Semenza (Nobel Laureate & Professor at Johns Hopkins School of Medicine), among others. Additional notable participants include President and CEO of Olympus, Mr. Stefan Kaufmann; CEO of Providence, Dr. Rod Hochman, M.D.; and Global Operating Partner of Advent International, Mr. Stefan Stoffel.
Expectations are high for BioAsia 2024, projected to attract over 3000 participants, providing a dynamic platform for networking and collaboration. The event will also showcase an expanded exhibition featuring more than 200 companies presenting groundbreaking advancements and cutting-edge products.
As Hyderabad welcomes influential leaders from around the globe, BioAsia 2024 aims to foster knowledge exchange and innovation in the life sciences and biotechnology sector. The event will serve as a global platform for promising startups in the pharmaceutical, biotech, life sciences, health-tech, and med-tech sectors to showcase their inventive concepts.
Mr. Sridhar Babu, Hon Minister for Industries & Commerce Dept., Government of Telangana, expressed his enthusiasm for the event’s growing global stature, emphasizing its critical role in the development of the Indian and global life sciences industries. Mr. Jayesh Ranjan, IAS, Principal Secretary, Industries & Commerce Department, of Telangana, highlighted BioAsia’s unmatched contribution to the revitalization of the life sciences industry over the past two decades.
Mr. Shakthi Nagappan, Director of Life Sciences, Govt. of Telangana, and CEO of BioAsia, sees the 21st edition as a milestone event, envisioning it as a platform to bridge gaps in the healthcare industry and foster innovation in critical sectors. With EY as the knowledge partner, the event will focus on themes such as Transformative Innovation, R&D, Patent Paradox, India’s Bid for Global R&D Dominance & IP Dilemmas, Leading the Health-tech Revolution, The Next Normal, India at the Frontier of Pharma Services, and MedTech as the Place to Be—themes that are highly relevant to the current industry landscape.